Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
Titel:
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
Auteur:
Feagan, Brian G Sands, Bruce E Sandborn, William J Germinaro, Matthew Vetter, Marion Shao, Jie Sheng, Shihong Johanns, Jewel Panés, Julián